Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A OTT

Showing results (651-660 of 667) with videos related to

Pageof 67
Sort By:
Nature|July 6, 2017
An immunogenic personal neoantigen vaccine for patients with melanomaPatrick A Ott, Zhuting Hu, Derin B Keskin, et al.
Cell|July 11, 2025
A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanomaEryn Blass, Derin B Keskin, Chloe R Tu, et al.
Voprosy Virusologii|July 9, 2010
[Trends in the spread of pandemic influenza A(H1N1) swl in the Far East in 2009]M Iu Shchelkanov, D N L'vov, I T Fediakina, et al.
Nature|February 5, 2025
A neoantigen vaccine generates antitumour immunity in renal cell carcinomaDavid A Braun, Giorgia Moranzoni, Vipheaviny Chea, et al.
Kidney International|December 28, 2020
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplantNaoka Murakami, Patrick Mulvaney, Melissa Danesh, et al.
Nature|December 21, 2018
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trialDerin B Keskin, Annabelle J Anandappa, Jing Sun, et al.
Cell|November 3, 2018
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby-Arnon, Parin Shah, Michael S Cuoco, et al.
Nature Medicine|January 6, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialJuanita Lopez, Thomas Powles, Fadi Braiteh, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 22, 2025
CefiderocolFinder: a tool for detecting genetic adaptations implicated in cefiderocol resistanceBryan van den Brand, Daan W Notermans, Nelianne J Verkaik, et al.
Voprosy Virusologii|October 5, 2010
[A possible association of fatal pneumonia with mutations of pandemic influenza A/H1N1 sw1 virus in the receptor-binding site of the HA1 subunit]D K L'vov, E I Burtseva, A G Prilipov, et al.
Pageof 67

Showing results (651-660 of 667) with videos related to

Sort By:
Pageof 67
Nature|July 6, 2017
An immunogenic personal neoantigen vaccine for patients with melanomaPatrick A Ott, Zhuting Hu, Derin B Keskin, et al.
Cell|July 11, 2025
A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanomaEryn Blass, Derin B Keskin, Chloe R Tu, et al.
Voprosy Virusologii|July 9, 2010
[Trends in the spread of pandemic influenza A(H1N1) swl in the Far East in 2009]M Iu Shchelkanov, D N L'vov, I T Fediakina, et al.
Nature|February 5, 2025
A neoantigen vaccine generates antitumour immunity in renal cell carcinomaDavid A Braun, Giorgia Moranzoni, Vipheaviny Chea, et al.
Kidney International|December 28, 2020
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplantNaoka Murakami, Patrick Mulvaney, Melissa Danesh, et al.
Nature|December 21, 2018
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trialDerin B Keskin, Annabelle J Anandappa, Jing Sun, et al.
Cell|November 3, 2018
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby-Arnon, Parin Shah, Michael S Cuoco, et al.
Nature Medicine|January 6, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialJuanita Lopez, Thomas Powles, Fadi Braiteh, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 22, 2025
CefiderocolFinder: a tool for detecting genetic adaptations implicated in cefiderocol resistanceBryan van den Brand, Daan W Notermans, Nelianne J Verkaik, et al.
Voprosy Virusologii|October 5, 2010
[A possible association of fatal pneumonia with mutations of pandemic influenza A/H1N1 sw1 virus in the receptor-binding site of the HA1 subunit]D K L'vov, E I Burtseva, A G Prilipov, et al.
Pageof 67